There Will be Less Money for Implementation of Federal Target Program Pharma-2020
Funding of the Federal Target Program Pharma-2020 reduced by 21.8 per cent to 135,331 bln rubles. Dmitriy Medvedev, Government Chair signed a relevant resolution introducing changes into the Federal Target Program Development of Pharmaceutical and Healthcare Industry of the Russian Federation up to 2020 and further.
Funding of R&D and design and experimental works has been reduced from 86,895 bln to 61,386 bln rubles, capital investments will be reduced from 20,768 bln rubles to 19,663 bln. Rubles.
Funding out of Federal Budget will be reduced from 110,185 bln to 83.561 bln rubles, funding from extrabudgetary sources – from 62.8 bln rubles to 51,77 bln rubles.